Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ito, M.
Right arrow Articles by Takuma, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, M.
Right arrow Articles by Takuma, Y.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Current Therapy for West Syndrome in Japan

Masatoshi Ito, MD

Department of Pediatrics Shiga Medical Center for Children, m-ito{at}qa2.so-net.ne.jp

Tohru Seki, MD

Department of Nursing Kiryu Junior College

Yuichi Takuma, MD

Division of Neurology Tokyo Metropolitan Kiyose Children's Hospital Tokyo, Japan

We sent questionnaires concerning the current therapy for West syndrome to 208 institutions at which pediatric care members of the Japan Epilepsy Society were working. Of these, 129 (62%) institutions responded. Vitamin B6 was the preferred first-line drug, followed by the combination of vitamin B6 and valproate or mono-therapy with valproate. Corticotropin was the third choice among the drugs. The dosage of corticotropin was lower than previously reported. The treatment of West syndrome is not well established at present and further research is needed to improve the therapeutic protocol. (J Child Neurol 2000; 15:424-428).

Journal of Child Neurology, Vol. 15, No. 6, 424-428 (2000)
DOI: 10.1177/088307380001500615
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
T. Tsuji, A. Okumura, H. Ozawa, M. Ito, and K. Watanabe
Current Treatment of West Syndrome in Japan
J Child Neurol, May 1, 2007; 22(5): 560 - 564.
[Abstract] [PDF]

Home page
 Arch. Dis. Child.Home page
H-S Wang, M-F Kuo, M-L Chou, P-C Hung, K-L Lin, M-Y Hsieh, and M-Y Chang
Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy
Arch. Dis. Child., May 1, 2005; 90(5): 512 - 515.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. T. Mackay, S. K. Weiss, T. Adams-Webber, S. Ashwal, D. Stephens, K. Ballaban-Gill, T. Z. Baram, M. Duchowny, D. Hirtz, J. M. Pellock, et al.
Practice Parameter: Medical Treatment of Infantile Spasms: Report of the American Academy of Neurology and the Child Neurology Society
Neurology, May 25, 2004; 62(10): 1668 - 1681.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Ito, H. Aiba, K. Hashimoto, S. Kuroki, K. Tomiwa, T. Okuno, H. Hattori, T. Go, H. Sejima, S. Dejima, et al.
Low-dose ACTH therapy for West syndrome: Initial effects and long-term outcome
Neurology, January 8, 2002; 58(1): 110 - 114.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
W. D. Shields
West's Syndrome
J Child Neurol, January 1, 2002; 17(1_suppl): S76 - S79.
[Abstract] [PDF]